Novo Nordisk Clinical Trial Call Center

Columbus, Ohio 43214

0 studies enrolling now · 2 studies all time

What they study most

Acquired Bleeding Disorder, Congenital Bleeding Disorder, Congenital FXIII Deficiency, Trauma

Studies at this site

• Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency — Completed
• Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma — Withdrawn before enrolling